133 related articles for article (PubMed ID: 16337261)
1. MCL0042: a nonpeptidic MC4 receptor antagonist and serotonin reuptake inhibitor with anxiolytic- and antidepressant-like activity.
Chaki S; Oshida Y; Ogawa S; Funakoshi T; Shimazaki T; Okubo T; Nakazato A; Okuyama S
Pharmacol Biochem Behav; 2005 Dec; 82(4):621-6. PubMed ID: 16337261
[TBL] [Abstract][Full Text] [Related]
2. Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor.
Chaki S; Hirota S; Funakoshi T; Suzuki Y; Suetake S; Okubo T; Ishii T; Nakazato A; Okuyama S
J Pharmacol Exp Ther; 2003 Feb; 304(2):818-26. PubMed ID: 12538838
[TBL] [Abstract][Full Text] [Related]
3. Anxiolytic-like effect of a selective and non-peptidergic melanocortin 4 receptor antagonist, MCL0129, in a social interaction test.
Shimazaki T; Chaki S
Pharmacol Biochem Behav; 2005 Mar; 80(3):395-400. PubMed ID: 15740781
[TBL] [Abstract][Full Text] [Related]
4. Novel piperazines: potent melanocortin-4 receptor antagonists with anxiolytic-like activity.
Nozawa D; Okubo T; Ishii T; Takamori K; Chaki S; Okuyama S; Nakazato A
Bioorg Med Chem; 2007 Mar; 15(6):2375-85. PubMed ID: 17267226
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the melanocortin MC4 receptor in stress-related behavior in rodents.
Chaki S; Ogawa S; Toda Y; Funakoshi T; Okuyama S
Eur J Pharmacol; 2003 Aug; 474(1):95-101. PubMed ID: 12909200
[TBL] [Abstract][Full Text] [Related]
6. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
[TBL] [Abstract][Full Text] [Related]
7. Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties.
Artaiz I; Zazpe A; Innerárity A; Del Olmo E; Díaz A; Ruiz-Ortega JA; Castro E; Pena R; Labeaga L; Pazos A; Orjales A
Psychopharmacology (Berl); 2005 Nov; 182(3):400-13. PubMed ID: 16032410
[TBL] [Abstract][Full Text] [Related]
8. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
[TBL] [Abstract][Full Text] [Related]
9. S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: a comparison to aprepitant (MK869) and paroxetine.
Millan MJ; Dekeyne A; Gobert A; Mannoury la Cour C; Brocco M; Rivet JM; Di Cara B; Lejeune F; Cremers TI; Flik G; de Jong TR; Olivier B; de Nanteuil G
Eur Neuropsychopharmacol; 2010 Sep; 20(9):599-621. PubMed ID: 20483567
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats.
Wesołowska A; Paluchowska MH; Gołembiowska K; Chojnacka-Wójcik E
J Pharm Pharmacol; 2003 Apr; 55(4):533-43. PubMed ID: 12803776
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological properties of vortioxetine and its pre-clinical consequences].
David DJ; Tritschler L; Guilloux JP; Gardier AM; Sanchez C; Gaillard R
Encephale; 2016 Feb; 42(1 Suppl 1):1S12-23. PubMed ID: 26879252
[TBL] [Abstract][Full Text] [Related]
12. SB-649915-B, a novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor, is anxiolytic and displays fast onset activity in the rat high light social interaction test.
Starr KR; Price GW; Watson JM; Atkinson PJ; Arban R; Melotto S; Dawson LA; Hagan JJ; Upton N; Duxon MS
Neuropsychopharmacology; 2007 Oct; 32(10):2163-72. PubMed ID: 17356576
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1S,2S)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS).
Liang Y; Shaw AM; Boules M; Briody S; Robinson J; Oliveros A; Blazar E; Williams K; Zhang Y; Carlier PR; Richelson E
J Pharmacol Exp Ther; 2008 Nov; 327(2):573-83. PubMed ID: 18689611
[TBL] [Abstract][Full Text] [Related]
14. Effect of co-administration of the selective 5-HT1A receptor antagonist WAY 100,635 and selective 5-HT1B/1D receptor antagonist GR 127,935 on anxiolytic effect of citalopram in conditioned fear stress in the rat.
Muraki I; Inoue T; Koyama T
Eur J Pharmacol; 2008 May; 586(1-3):171-8. PubMed ID: 18423441
[TBL] [Abstract][Full Text] [Related]
15. Acute antidepressant and anxiolytic effects of simvastatin and its mechanisms in rats.
Kilic FS; Ozatik Y; Kaygisiz B; Baydemir C; Erol K
Neurosciences (Riyadh); 2012 Jan; 17(1):39-43. PubMed ID: 22246008
[TBL] [Abstract][Full Text] [Related]
16. Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450.
Chaki S; Nakazato A; Kennis L; Nakamura M; Mackie C; Sugiura M; Vinken P; Ashton D; Langlois X; Steckler T
Eur J Pharmacol; 2004 Feb; 485(1-3):145-58. PubMed ID: 14757135
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
Tordera RM; Monge A; Del Río J; Lasheras B
Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
[TBL] [Abstract][Full Text] [Related]
18. Onset of the effects of the 5-HT1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat.
Cryan JF; McGrath C; Leonard BE; Norman TR
Pharmacol Biochem Behav; 1999 Jun; 63(2):333-8. PubMed ID: 10371664
[TBL] [Abstract][Full Text] [Related]
19. Assessing anxiolytic-like effects of selective serotonin reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors using the elevated plus maze in mice.
Takeuchi T; Owa T; Nishino T; Kamei C
Methods Find Exp Clin Pharmacol; 2010 Mar; 32(2):113-21. PubMed ID: 20401348
[TBL] [Abstract][Full Text] [Related]
20. The effects of the co-administration of the α₁-adrenoreceptor antagonist prazosin on the anxiolytic effect of citalopram in conditioned fear stress in the rat.
Takamura N; Masuda T; Inoue T; Nakagawa S; Koyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):107-11. PubMed ID: 22658980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
